Health & Fitness
Health and Fitness
Health and Fitness
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Trimel Appoints John Friedrichsen to Its Board of Director
October 13, 2011 15:50 ET
Trimel Appoints John Friedrichsen to Its Board of Director
- R. Anthony Pullen Joins Boards of Trimel Barbados Subsidiaries
TORONTO, ONTARIO--(Marketwire - Oct. 13, 2011) - Trimel Pharmaceuticals Corporation (TSX:TRL) today announced the appointment of Mr. John Friedrichsen to its Board of Directors. Mr. Friedrichsen is a Chartered Accountant and the Senior Vice President and Chief Financial Officer at FirstService Corporation. Mr. Friedrichsen has been actively involved in over 90 business acquisitions, integrations and numerous capital market transactions which have contributed to an increase in enterprise value for FirstService from $460 million to $1.5 billion and an increase in revenue from $200 million to over $2 billion. FirstService Corporation is a global leader in the rapidly growing real estate services sector, providing a variety of services in commercial real estate, residential property management and property services.
Chairman of the Board and Chief Executive Officer Bruce Brydon commented, "the addition of John Friedrichsen to Trimel's Board speaks to commitment to good governance and hence shareholder alignment. John's experience, skills and TSX experience complement and strengthen the Board's oversight".
Separately, Trimel BioPharma Holdings Inc. (Trimel Holdings) and Trimel BioPharma SRL (SRL) announced today that they have appointed R. Anthony (Tony) Pullen to their respective Boards of Directors. Mr. Pullen brings over 40 years of capital market and healthcare related experience to these Boards.
Robert Podruzny, Chairman of the Trimel Holdings and SRL Boards commented, "Tony brings extensive healthcare industry experience to our Boards and will provide tremendous insight and support as we look to partner our lead products which target the areas of male testosterone replacement and female sexual dysfunction".
About Trimel
Trimel Pharmaceuticals Corporation (TSX:TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRT, a bio-adhesive intranasal Testosterone gel for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit [ www.trimelpharmaceuticals.com ].
